Cargando…
USE OF DIFFERENT I(181)-LABELLED ANTIBODY ELUATES IN THE CHARACTERIZATION OF SHIGELLA AND VIBRIO ANTISERA
The results presented indicate that blocking curves of decreased slope are obtained with the Talmage test when the labelled antibody eluate contains a portion of antibody which is not represented in the unknown serum. The blocking curves of late antisera had steeper slopes than those of early antise...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1957
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2136716/ https://www.ncbi.nlm.nih.gov/pubmed/13428930 |
_version_ | 1782143184490463232 |
---|---|
author | Freter, Rolf |
author_facet | Freter, Rolf |
author_sort | Freter, Rolf |
collection | PubMed |
description | The results presented indicate that blocking curves of decreased slope are obtained with the Talmage test when the labelled antibody eluate contains a portion of antibody which is not represented in the unknown serum. The blocking curves of late antisera had steeper slopes than those of early antisera when tested against labelled antibody eluates prepared from late antisera. This situation was reversed when labelled eluates from early antisera were used in the Talmage test. The findings were interpreted to indicate that early antisera did not have a full complement of antibodies, directed against all surface antigens of the bacterial cell. |
format | Text |
id | pubmed-2136716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1957 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21367162008-04-17 USE OF DIFFERENT I(181)-LABELLED ANTIBODY ELUATES IN THE CHARACTERIZATION OF SHIGELLA AND VIBRIO ANTISERA Freter, Rolf J Exp Med Article The results presented indicate that blocking curves of decreased slope are obtained with the Talmage test when the labelled antibody eluate contains a portion of antibody which is not represented in the unknown serum. The blocking curves of late antisera had steeper slopes than those of early antisera when tested against labelled antibody eluates prepared from late antisera. This situation was reversed when labelled eluates from early antisera were used in the Talmage test. The findings were interpreted to indicate that early antisera did not have a full complement of antibodies, directed against all surface antigens of the bacterial cell. The Rockefeller University Press 1957-06-01 /pmc/articles/PMC2136716/ /pubmed/13428930 Text en Copyright © Copyright, 1957, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Freter, Rolf USE OF DIFFERENT I(181)-LABELLED ANTIBODY ELUATES IN THE CHARACTERIZATION OF SHIGELLA AND VIBRIO ANTISERA |
title | USE OF DIFFERENT I(181)-LABELLED ANTIBODY ELUATES IN THE CHARACTERIZATION OF SHIGELLA AND VIBRIO ANTISERA |
title_full | USE OF DIFFERENT I(181)-LABELLED ANTIBODY ELUATES IN THE CHARACTERIZATION OF SHIGELLA AND VIBRIO ANTISERA |
title_fullStr | USE OF DIFFERENT I(181)-LABELLED ANTIBODY ELUATES IN THE CHARACTERIZATION OF SHIGELLA AND VIBRIO ANTISERA |
title_full_unstemmed | USE OF DIFFERENT I(181)-LABELLED ANTIBODY ELUATES IN THE CHARACTERIZATION OF SHIGELLA AND VIBRIO ANTISERA |
title_short | USE OF DIFFERENT I(181)-LABELLED ANTIBODY ELUATES IN THE CHARACTERIZATION OF SHIGELLA AND VIBRIO ANTISERA |
title_sort | use of different i(181)-labelled antibody eluates in the characterization of shigella and vibrio antisera |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2136716/ https://www.ncbi.nlm.nih.gov/pubmed/13428930 |
work_keys_str_mv | AT freterrolf useofdifferenti181labelledantibodyeluatesinthecharacterizationofshigellaandvibrioantisera |